VivaChek Biotech Achieves FDA Clearance for Three Innovative Glucose Meters

We are excited to announce that VivaChek Biotech has received FDA clearance for three of its glucose meters featuring advanced FAD enzyme technology. This key milestone underscores the company’s steadfast commitment to driving innovation and maintaining the highest quality standards in healthcare.

The FDA clearance covers the following devices:

VivaChek™ FAD Blood Glucose Monitoring System

VivaChek™ FAD Smart Blood Glucose Monitoring System

VivaChek™ FAD Sync Blood Glucose Monitoring System

These devices are designed to deliver reliable and precise blood glucose measurements, empowering users to confidently manage their health. The FDA clearance is a testament to VivaChek Biotech’s dedication to providing superior healthcare solutions globally.

This achievement not only strengthens VivaChek Biotech’s standing as a leader in the medical device industry but also sets the stage for future advancements in blood glucose monitoring technology.

VivaChek Biotech remains committed to its mission of making healthcare more accessible and effective for all. The company continues to invest in research and development to ensure its products uphold the highest standards of quality and dependability.

For more information about VivaChek Biotech and its products, please visit www.vivachek.com.